Close
Home - Press releases - Ethypharm has obtained marketing authorisations for the first Immediate Release orodispersible tablets of morphine in Germany, France and the United Kingdom.

Do you have
any question?

Contact us
02/12/2021

Ethypharm has obtained marketing authorisations for the first Immediate Release orodispersible tablets of morphine in Germany, France and the United Kingdom.

Saint-Cloud, France – December 2nd, 2021 – Ethypharm has successfully used a European decentralized procedure to obtain its marketing authorisations (MA) for the 1st Immediate-Release orodispersible tablets of morphine in a broad range of dosages. This full in-house development will help Ethypharm to respond to some patients’ specific needs in the field of pain in the three largest European morphine markets: Germany, France and the United Kingdom.

Press release

Media enquiries

Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
(+)
Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
*All fields must be filled in

Thank you for your message!
We will examine it with utmost attention and get back to you shortly.